BioCardia
BCDA
21 hedge funds and large institutions have $1.65M invested in BioCardia in 2026 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.
98% more capital invested
Capital invested by funds: $831K → $1.65M (+$816K)
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
17% more funds holding
Funds holding: 18 → 21 (+3)
5.45% more ownership
Funds ownership: 6.28% → 11.72% (+5.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$419K |
| 2 |
CM
CM Management
Gulf Breeze,
Florida
|
+$179K |
| 3 |
PP
Pingora Partners
Wilson,
Wyoming
|
+$89.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$81.8K |
| 5 |
SG
StoneX Group
New York
|
+$21.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$42.6K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$29.4K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$29.1K |
| 4 |
VF
Virtu Financial
New York
|
-$25K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$17.9K |
BCDA Hedge Fund Activity: Q2 2026 in Review
21 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q2 2026, worth a combined $1.65M — up 98% from $831K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new BCDA positions and 5 closed out — a net gain of 3 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Citigroup, opening a new position worth an estimated $419K. The largest seller was Citadel Advisors, cutting an estimated $42.6K.
- 21 institutional investors held BioCardia (BCDA) as of Q2 2026, up from 18 in Q1 2026.
- Funds reported $1.65M of BioCardia stock for Q2 2026, up 98% quarter-over-quarter.
- 8 funds opened new BioCardia positions in Q2 2026 and 5 closed out, a net change of +3 holders.
- The largest BioCardia buyer in Q2 2026 was Citigroup, an estimated $419K added.
- The largest BioCardia seller in Q2 2026 was Citadel Advisors, an estimated $42.6K sold.
Based on aggregated 13F filings for Q2 2026.